Blanket purchase agreement for ravicti, buphenyl, krystexxa, procysbi, actimmune
Ended Awarded Last action
- Contract number
- 36E79719A0032
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 3 $392,388 obligated
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Horizon Pharma USA, Inc. Contract Award Effective 8/15/2019 65IB, 36F79719D0224 Effective 8-15-2019 - 8-14-2019 Award Notice · Posted Oct 11, 2019
- Combined order value
- $392,388 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 2% used
- $18,045,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Procurement for pegloticase 8MG/ML INJ soln | Veterans Integrated Service Network 22 (VHA) | $281,498 | |
| Krystexxa 8MG/ML | Veterans Integrated Service Network 2 (VHA) | $65,686 | |
| Krystexxa medication / VISN 2 / syracuse VAMC / FY20 / Q1 | Veterans Integrated Service Network 2 (VHA) | $45,203 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 15
Quick answers
Who was awarded contract 36E79719A0032?
36E79719A0032 was awarded to Horizon Therapeutics Usa, Inc. by National Acquisition Center (Headquarters) on September 20, 2019.
How much is contract 36E79719A0032 worth?
Orders under 36E79719A0032 have obligated $392,388. 36E79719A0032's own ceiling is $18,045,000.
How many orders have been placed under contract 36E79719A0032?
3 orders have been placed under 36E79719A0032, the latest on March 16, 2022.
Who can order from contract 36E79719A0032?
36E79719A0032 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79719A0032 under another contract?
Yes. 36E79719A0032 is a blanket purchase agreement under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79719A0032 competed?
The extent of competition for 36E79719A0032 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV